The mission of the Flow Cytometry Shared Resource (also known as FACS) Facility is to provide state-of-the-art highly available flow cytometry and cell-sorting services to the Stanford research community. To fulfill this mission, the Facility maintains three cell sorters and four flow analyzers in the Beckman Center in the School of Medicine. Four full-time and seven part-time staff work in the Facility, providing quality control, maintenance and operation of these instruments, as well as user training and consultation on experimental design and data analysis. The staff embodies over 125 years of flow cytometry experience, including developing some of the major advances of the field, such as compensation, cloning and large numbers of measurement parameters. The Facility Faculty Advisor is also highly experienced with flow cytometry, having used it as a research tool and helped to develop new applications over a 15-year period. The Flow Cytometry Shared Resource Facility billed 10,094 hours for instrument use in 2008. This represented 389 users from 153 different laboratories at Stanford. Cancer Center members provide the majority of this use, representing 117 of the laboratories and logging 76% of the hours. The FY 2008-2009 budget is over $900,000 and is expected to grow as new instrumentation is added. Currently, instruments with greater capabilities are utilized at close to 100% capacity. To this end, a new high-end analyzer and cell sorter have recently been obtained. The future goals of the Facility include expanding its educational program and bringing in new technologies and instrumentation, in addition to continuing to providing the highest quality flow cytometry services to the Cancer Center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
United States
Zip Code
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Banerjee, Imon; Gensheimer, Michael Francis; Wood, Douglas J et al. (2018) Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Sci Rep 8:10037
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15

Showing the most recent 10 out of 322 publications